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Abstract 
Porcine epidemic diarrhea virus (PEDV) has caused economic losses in the Americas, Asia 
and Europe in recent years. Reliable serological assays are essential for epidemiological studies 
and vaccine evaluation. The objective of this study was to compare the ability of five enzyme-
linked immunosorbent assays (ELISAs) to detect antibodies against different PEDV strains in 
pig serum. A total of 732 serum samples from North American or European pigs were tested. 
Samples included experimental samples from pigs infected with classical (G1a PEDV) or 
variant genogroup 1 PEDV (G1b PEDV), pandemic genogroup 2 PEDV (G2b PEDV) or non-
infected controls. Field samples from herds with confirmed or unknown PEDV exposure were 
also used. Three indirect ELISAs based on G2b antigens (ELISAs 1, 2 and 3), a competitive 
ELISA based on the G2b antigen (ELISA 4) and a competitive ELISA based on the G1a antigen 
(ELISA 5) were compared. Overall, the tests had a moderate agreement (κ = 0.61). G1a PEDV 
infected pigs were earliest detected by ELISA 3, G1b PEDV infected pigs were earliest 
detected by ELISAs 4 and 5 and the performance of all tests was similar for the G2b PEDV 
group. ELISA 1 showed the overall lowest detection on experimentally and field derived 
samples. Diagnostic sensitivity and specificity with a 95% probability interval were estimated 
to be 68.2% (62.1 – 74.4%) and 97.5% (95.2 – 99.0%) for ELISA 1, 73.7% (71.5 – 79.6%) and 
98.4% (96.6 – 99.5%) for ELISA 2, 86.2% (81.1 – 90.6%) and 91.6% (87.7 – 94.8%) for 
ELISA 3, 78.3% (72.8 – 83.5%) and 99.7% (98.2 – 100%) for ELISA 4, and 93.5% (90.3 – 
96.0%) and 91.2% (83.8 – 97.9%) for ELISA 5. 
Differences in detection among assays seem to be more related to intrinsic factors of an assay 
than to the PEDV antigen used.  
 
Words: 288/400 
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1. Introduction 
Since the first observed porcine epidemic diarrhea virus (PEDV) outbreak in the UK in 
1971, the virus has been reported in swine producing countries in Europe, Asia, and more 
recently, in the Americas and Caribbean (Song et al., 2015). The PEDV is highly contagious 
and causes enteric disease characterized by acute vomiting and diarrhea in pigs of all ages and 
often with up to 100% of mortality in suckling pigs in naïve breeding herds (Saif et al., 2012). 
The virus belongs to the family Coronaviridae, genus Alphacoronavirus, along with 
transmissible gastroenteritis virus (TGEV) and porcine respiratory coronavirus (PRCV) 
(Masters, 2006). Coronaviruses contain four major structural proteins, the spike (S) protein, 
the envelope (E) protein, the membrane (M) protein and the nucleocapsid (N) protein (Brian 
and Baric, 2005).  
PEDV can be grouped into genogroups 1 (G1a and G1b) and 2 (G2a and G2b) strains 
based on amino acid differences in the N-terminal domain of the S gene (Huang et al., 2013; 
Lee, 2015). Most PEDV strains circulating in Europe and in Asia prior to 2010 belong to G1a, 
including the historical and vaccine strains, such as CV777 and DR-13 (Song and Park, 2012). 
Genogroup 1b strains, also known as S-INDEL strains, comprise new variant strains that 
contain genetic signatures of the classical G1a strains in their S gene and appear to have resulted 
from a recombination event between G1a and epidemic G2b viruses, also known as non-S-
INDEL or pandemic strains (Lee, 2015). Genogroup 1b strains have been reported in Asia, the 
North America and in Europe (Lee, 2015). Since 2010, large-scale outbreaks with higher 
mortality in suckling piglets than previously described in Asia have been associated with PEDV 
G2a isolates, which are restricted to Asia, and G2b isolates (Song et al., 2015). In 2013, a 
PEDV G2b isolate similar to PEDV strains circulating in China since 2011, was introduced 
into a swine dense area in the Midwest of the US. Following introduction, G2b PEDV spread 
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rapidly across the US, further into Canada, and also into swine producing countries in Latin 
America (Song et al., 2015).  
A number of methods have been used to demonstrate PEDV antibodies such as enzyme-
linked immunosorbent assays (ELISAs) and immunofluorescence assays (IFAs). Available 
assays are either based on the whole virus (WV) (Hofmann and Wyler, 1990; Oh et al., 2005; 
Thomas et al., 2015), the N protein (Hou et al., 2007; Okda et al., 2015) or the S protein (Gerber 
et al., 2014a; Knuchel et al., 1992). The N protein, the most abundant viral protein expressed 
in PEDV infected cells, is highly conserved among PEDV genogroups (96-99.7% amino acid 
identity). The amino acid identity of the PEDV N protein is lower than 35% when compared 
to other porcine coronaviruses, however, it contains epitopes highly conserved among the 
family Coronaviridae, and cross reaction with certain TGEV strains have been reported (Lin 
et al., 2015). An S-protein based ELISA has been shown to be more specific and sensitive than 
an N-protein based ELISA (Knuchel et al., 1992), however, it has been suggested that the high 
heterogeneity of the S1 protein among PEDV isolates within and between genogroups (91-
99.6% amino acid identity) could limit the sensitivity of S protein-based assays in the field (Lin 
et al., 2015).  
The objective of the current study was to assess the diagnostic performance of two 
commercial and three in-house enzyme immunoassays based on PEDV WV antigen, N proteins 
or the S1 protein. To evaluate the assays, serum samples obtained from pigs in research 
facilities in the US or Denmark and commercial operations in Italy and the US without 
exposure to PEDV, pigs experimentally infected with G1a PEDV, G1b PEDV or G2b PEDV 
strains and field serum samples with confirmed or unknown PEDV exposure were used. 
 
2. Material and Methods 
2.1. Serum samples  
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A total of 708 serum samples from pigs with known or unknown PEDV exposure status were 
included in this study. A sample size of 160 samples was calculated based on a conservative 
value of 0.5 for both sensitivity and specificity to warrant a probability of more than 99% and 
to obtain a 95% confidence interval half-width less than or equal to 0.1 in the estimation of one 
sample proportion. After meeting the minimum requirement, the total number of samples 
included in this study was based on purposefully collecting samples in farms with known 
coronaviruses status and on availability of convenience samples. The serum samples were 
obtained from pigs of different age groups: suckling (1 to 3-4 weeks of age), nursery (3-4 to 10 
weeks of age), grow-finish (10 to 25 weeks of age) pigs and adult (> 25 weeks of age) pigs. 
Some of the samples were selected from random submissions to Veterinary Diagnostic 
Laboratories and an age was not available. These samples were classified as “unknown age”. 
None of the herds vaccinated pigs against PEDV at the time of sample collection.   
2.1.1. Experimental samples with known PEDV exposure status 
The experimental protocols were approved by the Danish Animal Experimentation 
Inspectorate and by the Iowa State Institutional Animal Care and Use Committee and the 
Institutional Biosafety Committee. The 22 PEDV negative serum samples were obtained from 
US (19 samples/19 pigs) and Danish (3 samples/3 pigs) uninfected control pigs. Sixty-four 
serum samples were obtained from Danish pigs infected with a G1a PEDVstrain (15 samples/3 
pigs), US pigs infected with a G1b-PEDV strain (24 samples/6 pigs), and US pigs infected with 
a G2b-PEDV strain (25 samples/13 pigs). Specifically, the Danish samples were obtained from 
5-week-old pigs infected with PEDV G1a strain Br1/87 (Bridgen et al., 1993) at day post-
inoculation (dpi) 10, 14, 17, 21 and 28 (Lohse et al., in press). In addition, another set of 3-
week-old US samples was from pigs orally inoculated with PEDV G1b isolate 
USA/IL/2014/20697 P7 and samples were collected at dpi 7, 14, 21 and 28 (Chen et al., 2016b). 
Furthermore, one set of US samples was obtained from 3-week-old pigs infected with PEDV 
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G2b strain ISU13-19338E (GenBank n. KF650371) and collected at dpi 7, 14, and 21 (Gerber 
et al., 2014b; Opriessnig et al., 2014).  
2.1.2. Field samples with known PEDV exposure 
A total of 294 samples from US or Italian pigs from PEDV exposed or unexposed farms 
were used. The PEDV infection status of a given farm was determined based on demonstration 
of PEDV RNA in fecal samples by real-time reverse-transcriptase (RT)-PCR and presence of 
enteric signs. RT-PCRs were performed using a commercially available assay test (Tetracore, 
Rockville, US) at Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna 
"Bruno Ubertini" (IZSLER) or an in-house RT-PCR targeting the N gene at the Iowa State 
University Veterinary Diagnostic Laboratory (ISU-VDL) (Chen et al., 2014).  
Field samples with PEDV exposure. Twenty-five serum samples were collected from 
three Italian finishing pig farms 4-8 weeks after the start of a PEDV outbreak in 2006 (Martelli 
et al., 2008). Another 124 serum samples from nursery and grow-finish pigs were collected 
from 10 Italian farms between 2014 and 2015 4-8 weeks after the start of PEDV outbreaks in 
these farms. Sequencing analysis of the S1 gene from RT-PCR positive fecal samples identified 
a G1a PEDV strain in the 2006 outbreaks while G1b PEDV strains were identified in the 2014-
2015 outbreaks (Boniotti et al., 2016).  
Field samples without PEDV exposure. Farms were localized in areas with no previous 
history of enteric signs compatible with viral diarrhea, were PEDV RNA negative based on a 
single collection, and were considered non-exposed to PEDV. One-hundred serum samples 
were collected from five Italian farms in 2015. Samples were collected from nursery and grow-
finish pigs.   
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 Field samples with known PRCV or TGEV exposure. Forty four serum samples from 
nursery pigs without PEDV exposure were collected from four US farms in 2013; samples were 
positive for anti-PRCV (2 farms, n = 24) or anti-TGEV (2 farms, n = 20) antibodies by ELISA 
(Svanovir TGEV/PRCV-Ab, Boehringer Ingelheim Svanova, Uppsala, Sweden) (Gerber et al., 
2014a).  
Unknown exposure status 
  A total of 353 porcine serum samples originated from the US or Italy were used. 
Samples were arbitrarily selected and originated from 2014 pig case submissions to IZSLER 
(26 farms, n = 151) or to the ISU-VDL (36 farms, n = 202 which included14 nursery pigs, 17 
grow-finish pigs, 36 adult pigs and 135 pigs with unknown age) (Thachil et al., 2015).  
 
2.2. PEDV antibody detection assays 
A summary of the five assays used is presented in Table 1. All ELISAs were performed by 
personnel blinded to sample classification and without knowledge of the results obtained with 
any of the other ELISAs used in this comparison. All samples that originated from previous 
studies were (re)-tested with all five assays for the present study to account for any storage 
effect.      
  ELISA 1. The commercial G2b-PEDV N protein (NP)-based Swinecheck® PED 
indirect ELISA (Biovet, Quebec, Canada) was used according to the manufacturer's label 
instructions. The S/P ratios ≥0.4 were considered antibody positive and <0.4 as negative.  
ELISA 2. The G2b-PEDV NP-based ID Screen® PEDV Indirect Screening test (IDvet, 
Montpellier, France) was used according to the manufacturer's label instructions. An S/P % 
ratio ≥ 60% was considered antibody positive and < 60% was considered negative. 
ELISA 3. An in-house G2b-PEDV S1-based indirect ELISA was used as previously 
described (Gerber et al., 2014a). The S/P ratios of >0.2 were considered antibody positive, 
8 
 
between 0.14-0.2 as suspect and <0.14 as negative. Samples classified in the suspect range of 
the ELISA-3 were considered positive for analysis purposes.   
ELISA 4. The in-house G2b-PEDV NP-based ELISA ID Screen® PEDV Competition 
2.0 (IDvet, Montpellier, France) which is not commercially available was used. In brief, serum 
samples, diluted 1:2.5, were added to a G2b-PEDV NP protein coated 96-well plate for 2 h at 
37°C. After a washing step, a peroxidase-conjugated anti-PEDV NP protein antibody was 
added and incubated at 37°C for 30 min. The peroxidase reaction was visualized by using 
tetramethylbenzidine-hydrogen peroxide solution as the substrate for 15 min at room 
temperature and stopped by adding 100 μL of 0.5 M sulfuric acid to each well. Optical densities 
(OD) were measured at 450 nm using an ELISA plate reader. An S/N % ratios ≤ 60% was 
considered antibody positive and > 60% was considered negative.  
ELISA 5. An in-house G1a PEDV WV ELISA was used. In brief, a G1a PEDV strain 
CV777-based WV ELISA was developed and validated at IZSLER based on a double antibody 
sandwich previously described (Sozzi et al., 2010). The ELISA microplates were coated with 
the 1F12 capture monoclonal antibody (MAb) (Sozzi et al., 2010). Serum samples, diluted 1:4, 
were mixed with equal volumes of whole cell-cultured adapted PEDV strain CV777 which was 
inactivated with ß-propiolactone to conserve antigenic properties and pre-incubated in an 
auxiliary microplate for 1 h at 37°C. Then, 50 μl of the pre-incubated mixtures were transferred 
into a1F12 MAb-coated plate and the conjugated horseradish peroxidase MAb 4C3 (Sozzi et 
al., 2010) was added. Following a further 1h incubation at 37°C the plate was washed. The 
optimal antigen concentration of the inactivated WV ELISA to obtain an optical density value 
of 1.0-1.5 in absence of a testing sample has been previously determined by testing serial two-
fold dilutions of the cell supernatants. The colorimetric reaction was performed and optical 
densities (OD) were measured at 492 nm using an ELISA plate reader. Results were calculated 
by determining the absorbance value reduction, expressed as percentage of inhibition (PI) 
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having the control wells as reference. The antibody-blocking reaction was considered positive 
if the PI was ≥ 60%. 
  
2.3. Discrepant results  
Samples with discrepant results, defined as a sample that exhibited a positive result in 
one (or more) assay(s) and a negative result in another assay, were retested with all assays. For 
a given assay, discordant samples were tested two or three times and the final result was based 
on two coincident results independent of the retest results with any other assay. This approach 
was adopted according to standard practices in Veterinary Diagnostic Laboratories for samples 
with unexpected results. Initially, 153 samples were classified as discrepant. From those 138 
remained discrepant after retesting and 15 samples were reclassified. Samples that were 
positive by only one assay after retesting were submitted to the ISU-VDL for PEDV IFA-ISU 
(Thomas et al., 2015) and for the PEDV WV ELISA (abbreviated here as WV-ISU) (Thomas 
et al., 2015) in addition to submission to the DTU National Veterinary Laboratory in Denmark 
for a blocking ELISA (abbreviated here as DTU-bELISA) (Lohse et al., 2016).  
 
2.4. Statistical analysis  
Experimental samples were excluded from the statistical analysis. The sensitivity and 
specificity of the assays were estimated using the field samples with known or unknown PEDV 
infection status collected at a single time point by a Bayesian latent class model with Markov 
Chain Monte Carlo (MCMC) simulation. A five test, three population, conditional 
independence model was fitted using JAGS 4.2.0. For samples with known infection status, 
the test outcomes were modeled by Bernoulli random variables with “chance of 
positive=sensitivity” for positive infection status and “1-specificity” for negative infection 
status. For samples with unknown infection status, latent Bernoulli random variables were first 
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generated for the infection status, and then the test outcomes were generated conditional on the 
latent status. Non-informative prior Beta distributions (0.5,0.5) were used for the parameters 
in the Bayesian model, ie, sensitivities, specificities and prevalence. The simulation was 
conducted with 1 chain with 20,000 iterations and the first 10,000 iterations were discarded as 
burning stage. The Gelman and Rubin diagnostic was used to check the convergence of three 
MCMC chains run in parallel. 
The Cochran's Q test for matched data, followed by McNemar's test for pairwise 
comparisons was used to determine whether the proportions of positive samples were 
significantly different by assays. Differences among tests were considered significant if 
p < 0.05. For field samples, analysis kappa (κ) index was performed to determine the 
agreement of positive/negative results between assays. The strength of agreement was 
considered as described ≤0 = poor, 0.01–0.2 = slight, 0.21–0.4 = fair, 0.41–0.60 = moderate, 
0.61–0.80 = substantial, and 0.81–1 = almost perfect. Statistical analyses were performed 
using SAS Version 9.4 (SAS Institute, Inc., Cary, USA). 
 
3. Results 
3.1. PEDV antibody detection in experimentally infected pigs  
Results from experimentally infected pigs are summarized in Table 2. All 22 samples 
from PEDV unexposed pigs were negative by all assays. All five assays correctly identified at 
least one pig in each group of 3 to 6 pigs experimentally infected with G1a PEDV, G1b PEDV 
or G2b PEDV.  
Among the pigs infected with G1a PEDV, positive pigs were first recognized by ELISA 
3 at dpi 10, by ELISAs 1 and 4 at dpi 14 and by ELISAs 2 and 4 at dpi 28 (Table 2). Among 
the pigs infected with G1b PEDV, ELISAs 2 and 5 detected positive pigs by dpi 7. Among the 
pigs infected with the G2b-PEDV, all assays but ELISA 1 detected at least one positive pig at 
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dpi 7. After dpi 14 all assays had similar detection. Positive detection among the assays for a 
given dpi was not different although ELISA 1 presented the overall lowest numerical values.  
 
3.2. PEDV antibody detection in field serum samples 
Field samples with known PEDV exposure. All assays identified at least one positive 
sample in all of the 13 Italian PEDV exposed farms. In the 10 farms from which samples were 
collected during the G1b PEDV outbreaks in 2014/2015 the positive detection varied from 95-
100%. In the three farms from which samples were collected during the G1a PEDV outbreaks 
in 2006, the positive detection varied from 32 to 96% among assays (Table 3). Specifically, 
ELISA 5 detected 96.0% (24/25) positive samples from all three farms, ELISAs 2, 3 and 4 
detected 40.0% (10/25) to 52.0% (13/25) samples as positive and ELISA 1 detected 32.0% 
(8/25) samples as positive.  
3.2.1 Field samples without PEDV exposure. From the 100 samples originated from the 
five 2014/2015 Italian farms without known PEDV exposure, ELISA 3 identified 16% (Table 
4, Farm 6) of the samples as positive, ELISA 1 identified 6% (Farms 6, 5 and 7) positive 
samples and ELISA 2 (Farm 7) identified 1% positive samples. The positive sample detected 
by ELISA 2 on Farm 7 was also detected as positive by ELISA 1. The other ELISAs did not 
detect any positive sample in the PEDV negative samples set.      
3.2.2 Field samples with unknown PEDV exposure. ELISA 5 classified the highest 
number of positive samples collected in 2014/2015 from 26 Italian farms with unknown 
exposure (p <0.05) (Table 3). Specifically, ELISA 5 identified 88.4% (23/26) of the farms as 
PEDV positive, while ELISAs 1, 2, 3 and 4 classified 30.7% (8/26) to 50% (13/26) of the farms 
as PEDV positive. ELISA 3 classified the highest number of positive samples within the 36 
US farms with unknown exposure (p <0.05) (Table 3). ELISAs 1, 3, 4 and 5 classified 61.1% 
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(22/36) to 77.7% (28/36) of the farms as positive and ELISA 2 classified 44.4% (16/36) of the 
farms as positive.  
3.2.3 Overall agreement on all field serum samples regardless of PEDV exposure 
status. ELISA 5 presented the overall highest number of positive samples (48%, 315/647) and 
ELISAs 1 (28%, 175/622) and 4 (29%, 178/622) presented the lowest detection (Table 3). 
There was an overall substantial agreement (κ = 0.61) among assays. The agreement among 
assays was similar considering the sample set origin (Italy, κ = 0.61; US, κ = 0.56). 
Interestingly, the agreement among assays in the subset of samples originating from farms with 
known exposure to PEDV (n = 269) was substantial (overall agreement κ = 0.80, κ = 0.71-
0.95), while the agreement among assays on samples of unknown status (n = 353) was only 
fair (overall agreement κ = 0.31, κ = 0.16-0.62).  
 
3.3. Cross-reaction with other coronaviruses 
Among 44 TGEV or PRCV antibody positive serum samples, 1/24 anti-PRCV antibody 
positive sample and 2/20 anti-TGEV antibody positive samples reacted with ELISA 2 (Table 
3). Positive samples originated from Farm A, one of the two PRCV infected farms, and from 
Farm B, one of two TGEV infected farms (Table 4). ELISA 5 reacted with one TGEV antibody 
positive sample originating from Farm C. Positive signals on any of the PRCV or TGEV 
samples were not observed with the other ELISAs.  
 
3.4. Samples with discrepant results  
Samples with discrepant results (n = 138), defined as a sample that did not exhibit 
coincidental results with all assays, i.e., exhibited positive results in one or more assays and 
negative results in any of the other assays, were further evaluated based on sample availability. 
A total of 96 samples from 28 farms were selected and tested by an IFA and the WV-ISU 
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ELISA, and 83 of the 96 samples were tested by the DTU-bELISA (Table 4). The WV-ISU 
ELISA classified the highest number of farms as positive (23/26), including a sample on a 
PRCV positive, PEDV negative farm, while the IFA classified the lowest number of farms as 
positive (4/28). The DTU-bELISA classified 7/28 farms as positive.    
 
3.5. Estimate of diagnostic sensitivity and specificity  
Assays accuracy were estimated by using cumulative data using a Markov Chain Monte Carlo 
simulation. The estimate of expected predictive error (DIC) was 2947.5. Diagnostic sensitivity 
and specificity with a 95% probability interval were estimated to be 68.2% (62.1 – 74.4%) and 
97.5% (95.2 – 99.0%) for ELISA 1, 73.7% (71.5 – 79.6%) and 98.4% (96.6 – 99.5%) for 
ELISA 2, 86.2% (81.1 – 90.6%) and 91.6% (87.7 – 94.8%) for ELISA 3, 78.3% (72.8 – 83.5%) 
and 99.7% (98.2 – 100%) for ELISA 4, and 93.5% (90.3 – 96.0%) and 91.2% (83.8 – 97.9%) 
for ELISA 5.  
 
4. Discussion 
The ongoing large-scale PEDV outbreaks in the Americas, Asia and Europe demand 
specific PEDV detection tools such as serology for locating PEDV-exposed herds, to conduct 
epidemiological studies, and to do immunization efficacy studies (Lin et al., 2015). Challenges 
for accurate serological diagnosis for PEDV include the variability of viral genome and also 
the existence of common immunodominant sites among alphacoronaviruses (Lin et al., 2015). 
This includes TGEV that produces similar clinical and pathological signs as PEDV (Stevenson 
et al., 2013) and PRCV that is widespread in many geographic locations (Saif et al., 2012). In 
this study, the ability to detect antibodies against PEDV in pigs infected with G1 or G2 PEDV 
isolates was compared for five serological tests based on PEDV WV, the N protein or the S 
protein.  
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All five tested assays correctly identified pigs infected with G1a PEDV, G1b PEDV or 
G2b PEDV but with different detection proportions. None of the assays had a consistently 
higher detection across the different strains. It has been suggested that ELISAs based on WV 
or the N protein would be more sensitive for detection of antibodies against heterologous 
PEDV strains than ELISAs based on the S1 protein (Chen et al., 2016b; Lin et al., 2015). This 
could not be confirmed in the present study as by using the S1-based ELISA 3 pigs infected 
with G1a PEDV were identified up to four days earlier compared to all other assays, including 
ELISA 5 that is based on the whole virus of a G1a PEDV strain. ELISA 5 and N-based ELISA 
4 detected antibodies against G1b PEDV earlier compared to the S1-based ELISA 3. However, 
the latter had similar performance in the detection of the G1b PEDV sera compared to the other 
two N-based ELISAs indicating that other factors than the antigen used could contribute to 
differences in the sensitivity among assays.  
In the present study, the NP-based indirect ELISA 2 cross-reacted with 1/24 PRCV and 
2/20 TGEV positive serum samples, and the WV-based competitive ELISA 5 cross-reacted 
with a TGEV positive serum sample. Indirect ELISAs have the advantage of requiring only 
one anti-species specific conjugate targeting a particular antibody subset such as anti IgA or 
IgG that are readily available, making it suitable for wide use for screening large number of 
samples (Schrijver and Kramps, 1998). However, in indirect ELISAs, non-specific binding of 
antibodies is a common problem, because all antibodies that are bound in the well, either 
specifically or non-specifically, will be detected by the conjugated antibody, affecting its 
specificity (Schrijver and Kramps, 1998). On the other hand, competitive ELISAs are generally 
recognized as being more specific than indirect ELISAs because interference due to antibody 
non-specific binding generally does not bias the test result and allow the use of partially 
purified virus when highly purified MAbs are used (Schrijver and Kramps, 1998). Because of 
this characteristic, serum samples can be tested in low dilutions, which may contribute also to 
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a higher sensitivity of this format (OIE, 2015). However, unexpected interferences can also 
occur in competitive ELISAs. For example, purified WV contains all virally expressed 
proteins, which increases sensitivity but also increases the risk for cross-reaction with similar 
viruses (Simmons, 2008). Truncation of the antigenic site in the N protein N-terminal region 
to exclude the immunodominant cross-reactive epitope or the usage of S protein as antigen for 
PEDV serology has been suggested to improve specificity of the immunoassays (Lin et al., 
2015).  
ELISA 3 detected 16/34 samples from a PEDV non-exposed farm as positive. Another NP-
based assay (ELISA 1) also detected a single positive sample on the same farm. When the 
discrepant samples were further evaluated using an IFA, the indirect WV-ISU ELISA, the 
blocking DTU-bELISA contradictory results of these additional assays further complicated the 
serological diagnosis. As the 2015 non-exposed Italian farms were classified based on absence 
of clinical signs and PEDV RT-PCR negative results in fecal samples, the result suggests an 
unspecific reaction by one of the assays used. However, the high number of samples detected 
in a single farm (Farm 6) by ELISA 3 could indicate a cross-reaction with an unknown 
pathogen or a true positive result. Alignment of the S1 gene sequence and sequences publicly 
available through GenBank did not reveal similarities with any other pig pathogens (data not 
shown). Alternatively, the farm could have experienced a prior subclinical PEDV infection as 
the absence of PEDV RNA was based on a single point RT-PCR testing on ten fecal samples. 
Misclassifications of farms as “negative” could lead to artificially decreased specificity of 
assays. This bias in the specificity usually occurs because the positive serological results within 
these farms are classified as false-positives. As the farms classified as negative were excluded 
from the sensitivity analysis, this did not affect the estimated sensitivity. Previous studies have 
shown that PEDV antibodies in serum samples can be detected up to 7 months after initial 
exposure (Goede et al., 2015; Ouyang et al., 2015). Basing a negative farm classification on 
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testing fecal samples by RT-PCR at a single time point could easily lead to a misclassification 
if the farm had experienced a clinically not recognized PEDV infection weeks or months before 
the testing. Phylogenetic studies showed that the PEDV strains currently associated with PEDV 
outbreaks in Italy are G1b strains (Boniotti et al., 2016), which have been suggested to produce 
milder clinical signs when compared to G2b strains (Chen et al., 2016a).  
Although the evaluated assays presented an overall substantial agreement for the field 
samples from both tested countries, the agreement differed within subsets. The almost perfect 
agreement on the samples with known exposure may be explained by relative timing of PEDV 
infection (acute to subacute outbreaks) to sample collection and therefore the high number of 
positive samples, which could have artificially increased the estimates of sensitivity of the 
assays. In the unknown exposure set, samples likely contained animals in different phase of 
infection and samples with variable amounts of antibodies. Additionally, the unknown 
infection status for PEDV and other possible coronaviruses infections complicate the 
interpretation of discrepant results. ELISA 5, developed in Italy, had a much higher detection 
of positive serum samples in an Italian sample set with unknown PEDV exposure but not for 
the US subset of unknown samples. An increased positive detection by the competitive ELISA 
may be due to detection of IgA and IgM antibodies in addition to the IgG antibodies detected 
by the indirect ELISAs. However, the same trend was not observed with the competitive 
ELISA 4. Similarly, ELISA 3, developed in the US, had the highest detection among the US 
unknown samples subset. The sample set used for each assay optimization could partially 
explain the different detection proportions (Banoo et al., 2010) as the usage of same cut off for 
geographically different animal populations infected with different viral strains may result in 
different sensitivity and specificity. Similarly, the usage of only experimentally infected 
animals can lead to inflated estimates of accuracy when the samples have been collected only 
from animals at the peak of antibody production, or from animals from herds tested free for the 
17 
 
most pathogens (Banoo et al., 2010). Alternatively, a PEDV-TGEV recombinant virus was 
found to circulate in Italy during 2009-2012 (Boniotti et al., 2016). Although the PEDV-TGEV 
recombinant virus has not been detected after 2012 (Boniotti et al., 2016), the presence of 
unidentified recombinant enteric coronaviruses could perhaps partially explain a higher 
positive detection for the WV-based ELISA 5.  
Ideally, diagnostic specificity and sensitivity should be calculated using unequivocally 
true negative and true positive samples as determined by a combination of ‘gold standard’ 
methods (OIE, 2015). However, in the absence of ‘gold standard’ tests, latent-class models 
based on reference populations, and not individual reference samples can be used (OIE, 2015). 
In the present study, a Bayesian approach was used to estimate the assays accuracy. Measures 
of diagnostic accuracy are extremely sensitive to the design of the study and although the usage 
of samples from different geographical populations herein could potentially increase 
representativeness, the accuracy of the presented results should be interpreted with caution. 
When applying a diagnostic assay, laboratories should observe if the cut-off values are 
applicable in their specific context and revise diagnostic sensitivity and specificity as required 
(Crowther et al., 2006). It is critical that the diagnostic purpose of an assay is clearly defined 
in regard to the population to be tested (OIE, 2015). As diagnostic sensitivity and diagnostic 
specificity are usually inversely related and as such a decrease in diagnostic specificity will 
result in elevated false positive results. Tests with moderate to high diagnostic sensitivity and 
specificity balance the false positive and false negative results and give a more accurate 
estimate of prevalence of infection or vaccination within a population (OIE, 2015). The 
decision which assay should be used for PEDV antibodies monitoring at the herd level 
ultimately needs to be based on the expected prevalence of disease, desired specificity and 
sensitivity levels (screening or confirmatory test), easiness of testing, and access to a certain 
assay.   
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5. Conclusions 
In summary, the ELISA 1 had the overall lowest detection from sample subsets derived 
from both experimentally and naturally infected animals and ELISA 5 had the overall highest 
detection. 
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Table 1 
Summary of the enzyme-linked immunosorbent assays used in this study 
 
Assa
y  
Test 
principle 
Coating 
antigen 
PEDV 
genogro
up (G) 
Seru
m 
diluti
on 
Conjugate  
Total 
incubati
on time 
(h:m) 
Referenc
e 
ELIS
A 1 
Indirect 
Nucleoprot
ein 
G2b 1:200 
Anti-
porcine 
IgG 
03:10 
Swineche
ck PED 
indirect, 
Biovet 
ELIS
A 2 
Indirect 
Nucleoprot
ein 
G2b 1:10 
Protein 
A/G 
01:30 
IDScreen 
PEDV 
Indirect, 
IDvet 
ELIS
A 3 
Indirect Spike 1 G2b 1:100 
Anti-
porcine 
IgG 
01:10 
Gerber et 
al., 2014 
ELIS
A 4 
Competiti
ve 
Nucleoprot
ein 
G2b 1:2.5 
Anti-
PEDV 
nucleoprot
ein 
antibody 
02:45 
This 
study 
ELIS
A 5 
Competiti
ve 
Whole 
virus 
G1a 
1:2/1:
4 
Monoclon
al antibody 
anti-G1a 
PEDV 
02:15 
This 
study 
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Table 2 
Detection rates of anti-PEDV antibodies in serum samples of pigs experimentally infected 
with PEDV genogroup 1a (G1a) strain Br-1/87, PEDV G1b strain USA/IL/2014/20697, or 
PEDV genogroup 2b (G2b) US prototype strain ISU13-19338E at various days post infection 
tested by five different assays (ELISA 1, ELISA 2, ELISA 3, ELISA 4, ELISA 5). Values in 
parenthesis were classified as suspect.  
Assay 
Days post 
infection  
  
  
 
      
  
      
 G1a    G1b   G2b 
  10 14 17 21 28  7 14 21 28  7 14 21 
ELISA 
1  
0/3 2/3 2/3 2/3 2/3 
 
0/6 2/6 3/6 2/6  0/6 4/6 10/13 
ELISA 
2 
0/3 0/3 0/3 0/3 2/3 
 
2/6 5/6 5/6 5/6  1/6 4/6 13/13 
ELISA 
3 
1/3 3/3 3/3 3/3 3/3 
 
0/6 3(2)/6 4(1)/6 4/6  3/6 6/6 13/13 
ELISA 
4 
0/3 0/3 0/3 0/3 2/3 
 
0/6 2/6 6/6 6/6  2/6 4/6 13/13 
ELISA 
5 
0/3 1/3 1/3 1/3 1/3 
 
4/6 5/6 5/6 5/6  3/6 6/6 13/13 
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Table 3  
Detection rates of anti-PEDV antibodies in field serum samples tested by five different 
ELISAs (1 through 5). Samples were collected from pigs originating from Italian or US 
commercial farms with known or unknown PEDV exposure as determined by RT-PCR on 
fecal samples. 
 
Count
ry  
  
PEDV 
exposure  
 (Genogro
up) 
Year TGEV/PR
CV 
exposure 
N. 
sampl
es  
  
N. positive samples per assay   
ELIS
A 1  
ELIS
A 2 
ELIS
A 3 
ELIS
A 4 
ELIS
A 5 
Italy 
Exposed 
(G1a) 
2006 Unknown 
25 10b 13ab 13ab 8b 24a 
 
Exposed 
(G1b) 
2015 Unknown 
100 95 94 98 98 100 
 
Non-
exposed  
2015 Unknown 
100 5 1 16 0 0 
 Unknown  
2014/20
15 
Unknown 
151 10c 12c 21b 21b 108a 
          
US 
Non-
exposed  
2013 Exposed 
44 0 3 0 0 1 
  Unknown  2014 Unknown 202 37c 59b 69a 30c 55b 
Total    622 175d 211c 229b 178d 315a 
* Different superscripts (a, b, c) indicate difference of detection rates among kits for a given 
sample origin (McNemar’s test, p < 0.05). 
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Table 4 
Detection rates of anti-PEDV antibodies in field serum samples (n = 96) with discordant 
results, defined as a sample that exhibited a positive result in one or more ELISA and a 
negative result in another ELISA(s). Discordant samples were additionally tested by IFA, 
WV-ISU ELISA and the DTU-bELISA. Results were presented as number of positive tested 
samples for a given assay per farm. Light grey indicates that only one tested sample was 
positive with a given test and dark grey indicates that more than one sample was positive for 
a given test.  
Country  Year  Farm PEDV 
status 
ELISAs used in this study Confirmatory assays 
ELISA 
1 
ELISA 
2 
ELISA 
3 
ELISA 
4 
ELISA 
5 
IFA WV-
ISU 
DTU-
bELISA  
Italy 2014 1 Unknown 0/8 0/8 0/8 0/8 4/8 0/4 4/4 0/3 
Italy 2014 2 Unknown 0/1 0/1 0/1 0/1 1/1 1/1 1/1 1/1  
Italy 2014 3 Unknown 0/6 0/6 0/6 0/6 5/6 0/4 2/4 0/4 
Italy 2014 4 Unknown 0/8 0/8 0/8 0/8 7/8 0/7 3/7 3/7 
Italy 2014 8 Unknown 1/4 0/4 0/4 0/4 4/4 0/3 3/3 0/3 
Italy 2014 9 Unknown 0/6 0/6 0/6 1/6 2/6 0/1 0/1 0/1 
Italy 2014 10 Unknown 0/6 0/6 0/6 2/6 3/6 0/3 3/3 0/2 
Italy 2014 11 Unknown 0/8 0/8 0/8 4/8 5/8 0/3 3/3 1/2 
Italy 2014 12 Unknown 1/4 0/4 0/4 0/4 4/4 0/3 3/3 0/3 
Italy 2014 13 Unknown 0/2 0/2 0/2 1/2 2/2 0/1 0/1 0/1 
Italy 2014 14 Unknown 0/3 0/3 2/3 0/3 1/3 0/1 1/1 1/1 
Italy 2014 15 Unknown 2/4 0/4 0/4 0/4 3/4 0/1 1/1 0/1 
Italy 2014 16 Unknown 0/12 0/12 0/12 5/12 7/12 1/6 3/6 0/6 
Italy 2014 17 Unknown 0/3 1/3 0/3 1/3 3/3 0/2 2/2 2/2 
Italy 2014 18 Unknown 2/10 1/10 0/10 0/10 7/10 0/6 6/6 0/6 
Italy 2014 19 Unknown 1/4 1/4 2/4 1/4 4/4 0/3 2/2 0/1 
Italy 2014 20 Unknown 1/10 1/10 1/10 3/10 6/10 0/4 2/4 0/4 
Italy 2014 21 Unknown 1/6 2/6 0/6 2/6 3/6 0/3 3/3 0/1 
Italy 2014 22 Unknown 1/10 0/10 1/10 1/10 5/10 0/5 5/5 0/4 
Italy 2014 23 Unknown 0/9 1/9 2/9 0/9 8/9 0/4 2/4 0/4 
Italy 2014 25 Unknown 1/17 5/17 4/17 2/17 16/17 0/7 7/7 1/7 
Italy 2015 5 Non-
exposed 
2/18 0/18 0/18 0/18 0/18 1/2 1/2 0/2 
Italy 2015 6 Non-
exposed 
1/34 0/34 16/34 0/34 0/34 0/13 10/13 0/12 
Italy 2015 7 Non-
exposed 
3/20 1/20 0/20 0/20 0/20 0/2 2/2 0/22 
US 2013 A Non-
exposed 
0/6 1/6 6/6 0/6 0/6 5/5 1/1 0/3 
US 2013 B Non-
exposed 
0/10 2/10 0/10 0/10 0/10 0/2 nt nt 
US 2013 C Non-
exposed 
0/10 0/10 0/10 0/10 1/10 0/2 nt nt 
Italy 2015 24 Exposed 10/11 10/11 10/11 10/11 11/11 1/1 1/1 1/1 
*nt = not tested. 
 
